US FDA approves Merck's injectable version of blockbuster cancer therapy Keytruda – Reuters

Business News

  1. US FDA approves Merck’s injectable version of blockbuster cancer therapy Keytruda  Reuters
  2. FDA OKs New Keytruda Shot for Cancer  The New York Times
  3. Merck scores FDA approval for subcutaneous Keytruda, securing potential blockbuster protection  Fierce Pharma
  4. FDA Approves Subcutaneous Pembrolizumab for Solid Tumors  OncLive
  5. Merck wins approval of subcutaneous Keytruda, in bid to extend life of world’s top-selling drug  Endpoints News

Source: Business News

/by